Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · IEX Real-Time Price · USD
294.23
+10.78 (3.80%)
At close: Jul 19, 2024, 4:00 PM
294.22
-0.01 (0.00%)
After-hours: Jul 20, 2024, 12:58 PM EDT
Bio-Rad Laboratories Employees
Bio-Rad Laboratories had 8,030 employees as of December 31, 2023. The number of employees decreased by 170 or -2.07% compared to the previous year.
Employees
8,030
Change (1Y)
-170
Growth (1Y)
-2.07%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
8.33B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8,030 | -170 | -2.07% |
Dec 31, 2022 | 8,200 | 300 | 3.80% |
Dec 31, 2021 | 7,900 | -100 | -1.25% |
Dec 31, 2020 | 8,000 | -120 | -1.48% |
Dec 31, 2019 | 8,120 | -140 | -1.69% |
Dec 31, 2018 | 8,260 | 110 | 1.35% |
Dec 31, 2017 | 8,150 | -100 | -1.21% |
Dec 31, 2016 | 8,250 | 480 | 6.18% |
Dec 31, 2015 | 7,770 | 170 | 2.24% |
Dec 31, 2014 | 7,600 | -150 | -1.94% |
Dec 31, 2013 | 7,750 | 370 | 5.01% |
Dec 31, 2012 | 7,380 | 350 | 4.98% |
Dec 31, 2011 | 7,030 | 150 | 2.18% |
Dec 31, 2010 | 6,880 | 280 | 4.24% |
Dec 31, 2009 | 6,600 | 0 | - |
Dec 31, 2008 | 6,600 | 200 | 3.13% |
Dec 31, 2007 | 6,400 | 1,000 | 18.52% |
Dec 31, 2006 | 5,400 | 200 | 3.85% |
Dec 31, 2005 | 5,200 | 0 | - |
Dec 31, 2004 | 5,200 | 400 | 8.33% |
Dec 31, 2003 | 4,800 | 200 | 4.35% |
Dec 31, 2002 | 4,600 | 300 | 6.98% |
Dec 31, 2001 | 4,300 | 500 | 13.16% |
Dec 31, 2000 | 3,800 | -300 | -7.32% |
Dec 31, 1999 | 4,100 | 1,425 | 53.27% |
Dec 31, 1998 | 2,675 | 25 | 0.94% |
Dec 31, 1997 | 2,650 | 115 | 4.54% |
Dec 31, 1996 | 2,535 | 75 | 3.05% |
Dec 31, 1995 | 2,460 | 130 | 5.58% |
Dec 31, 1994 | 2,330 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Chemed | 15,087 |
Bio-Rad Laboratories | 8,030 |
Exact Sciences | 6,600 |
Roivant Sciences | 908 |
Lantheus Holdings | 834 |
Intra-Cellular Therapies | 610 |
BIO.B News
- 4 days ago - Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024 - Business Wire
- 7 weeks ago - Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group - Business Wire
- 2 months ago - Bio-Rad's Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip - Reuters
- 2 months ago - Bio-Rad Reports First-Quarter 2024 Financial Results - Business Wire
- 2 months ago - Bio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference - Business Wire
- 3 months ago - Bio-Rad Announces Life Science Group Management Changes - Business Wire
- 3 months ago - Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - Business Wire